A plasma N-acetyl amino acid panel for type 2 diabetes discrimination built by targeted LC–MS/MS: A case–control study - Scorecard - MDSpire

A plasma N-acetyl amino acid panel for type 2 diabetes discrimination built by targeted LC–MS/MS: A case–control study

  • By

  • Shusi Ding

  • Zhanxiong Xie

  • Daqiu Chen

  • Xiaomai Huang

  • Qiutong Wu

  • Lemin Zheng

  • Shanghua Xu

  • Shunxiang Luo

  • June 3, 2026

  • 0 min

Share

Clinical Scorecard: Targeted LC–MS/MS Analysis of Plasma N-acetyl Amino Acids for Differentiating Type 2 Diabetes: A Case-Control Investigation

At a Glance

CategoryDetail
Condition
Key MechanismsMetabolic disturbances linked to amino acid metabolism and acetylation status.
Target Population
Care Setting

Key Highlights

    Guideline-Based Recommendations

    Diagnosis

      Management

        Monitoring & Follow-up

          Risks

            Patient & Prescribing Data

            Individuals with Type 2 Diabetes and non-diabetic controls.

            NAcAAs may provide insights into metabolic shifts and risk stratification.

            Clinical Best Practices

              Related Resources & Content

              Original Source(s)

              Related Content